During the past decade, mutations affecting liability to central obesity have been discovered at a phenomenal rate, and despite few consistently replicated findings, a number of intriguing results have emerged in the literature. Association studies have been proposed to identify the genetic determinants of complex traits such as central obesity. The advantages of the association method include its relative robustness to genetic heterogeneity and the ability to detect much smaller effect sizes than is detectable using feasible sample sizes in linkage studies. However, the current literature linking central obesity to genetic variants is teeming with reports of associations that either cannot be replicated or for which corroboration by linkage has been impossible to find. Explanations for this lack of reproducibility are well rehearsed, and typically include poor study design, incorrect assumptions about the underlying genetic architecture, and simple overinterpretation of data. These limitations create concern about the validity of association studies and cause problems in establishing robust criteria for undertaking association studies. In this article, the current status of the literature of association studies for genetic dissection of central obesity is critically reviewed.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Hereditas Open Access 22 February 2016
Nature Communications Open Access 13 April 2015
Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies
Diabetologia Open Access 01 April 2011
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Björntorp P . Obesity. Lancet 1997; 350: 423–426.
Bouchard C . Genetic determinants of regional fat distribution. Hum Reprod 1997; 12: 1–5.
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation, World Health Organization Technical Report Series, Vol. 894, 2000, pp 1–253.
Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K . A comprehensive review of genetic association studies. Genet Med 2002; 4: 45–61.
Riley JH, Allan CJ, Lai E, Roses A . The use of single nucleotide polymorphisms in the isolation of common disease genes. Pharmacogenomics 2000; 1: 39–47.
Devlin B, Roeder K, Bacanu SA . Unbiased methods for population-based association studies. Genet Epidemiol 2001; 21: 273–284.
Cardon LR, Bell JI . Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91–99.
Weiss KM, Terwilliger JD . How many diseases does it take to map a gene with SNPs? Nat Genet 2000; 26: 151–157.
Risch NJ . Searching for genetic determinants in the new millennium. Nature 2000; 405: 847–856.
Risch N . Evolving methods in genetic epidemiology. II. Genetic linkage from an epidemiologic perspective. Epidemiol Rev 1997; 19: 24–32.
Potter JD . At the interfaces of epidemiology, genetics and genomics. Nat Rev Genet 2001; 2: 142–147.
Clayton D, McKeigue PM . Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358: 1356–1360.
Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C . The human obesity gene map: the 2001 update. Obes Res 2002; 10: 196–243.
Argyropoulos G, Rankinen T, Neufeld DR, Rice T, Province MA, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C . A polymorphism in the human agouti-related protein is associated with late-onset obesity. J Clin Endocrinol Metab 2002; 87: 4198–4202.
Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V, Doria A . A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306–2312.
Meirhaeghe A, Helbecque N, Cottel D, Amouyel P . β2-Adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 1999; 353: 896.
Meirhaeghe A, Helbecque N, Cottel D, Amouyel P . Impact of polymorphisms of the human β2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord 2000; 24: 382–387.
Rosmond R, Ukkola O, Chagnon M, Bouchard C, Björntorp P . Polymorphisms of the β2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 2000; 248: 239–244.
Ukkola O, Perusse L, Chagnon YC, Despres JP, Bouchard C . Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int J Obes Relat Metab Disord 2001; 25: 1332–1339.
Widén E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC . Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348–351.
Kurabayashi T, Carey DG, Morrison NA . The β3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996; 45: 1358–1363.
Sakane N, Yoshida T, Umekawa T, Kondo M, Sakai Y, Takahashi T . β3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 1997; 40: 200–204.
Sakane N, Yoshida T, Umekawa T, Kogure A, Takakura Y, Kondo M . Effects of Trp64Arg mutation in the β3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 1997; 20: 1887–1890.
Kim-Motoyama H, Yasuda K, Yamaguchi T, Yamada N, Katakura T, Shuldiner AR, Akanuma Y, Ohashi Y, Yazaki Y, Kadowaki T . A mutation of the β3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 1997; 40: 469–472.
Mitchell BD, Blangero J, Comuzzie AG, Almasy LA, Shuldiner AR, Silver K, Stern MP, MacCluer JW, Hixson JE . A paired sibling analysis of the β3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 1998; 101: 584–587.
Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G, Barvato A, D'Elia L, Trevisan M, Farinaro E . Relationship of the Trp64Arg polymorphism of the β3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 2001; 19: 399–406.
van't Hooft FM, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A . Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 2001; 104: 1223–1228.
Fisher RM, Burke H, Nicaud V, Ehnholm C, Humphries SE . Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. EARS Group. J Lipid Res 1999; 40: 287–294.
Pouliot MC, Despres JP, Dionne FT, Vohl MC, Moorjani S, Prud'homme D, Bouchard C, Lupien PJ . ApoB-100 gene EcoRI polymorphism. Relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb 1994; 14: 527–533.
Oh JY, Barrett-Connor E . Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study. Clin Genet 2001; 60: 132–137.
Wolford JK, Bogardus C, Prochazka M . Polymorphism in the 3′ untranslated region of MTG8 is associated with obesity in Pima Indian males. Biochem Biophys Res Commun 1998; 246: 624–626.
Baghaei F, Rosmond R, Westberg L, Hellstrand M, Landén M, Eriksson E, Holm G, Bjorntorp P . The lean woman. Obes Res 2002; 10: 115–121.
Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takacs I, Lakatos P . Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 2001; 144: 385–389.
Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A, Koyama W, Nonaka K . Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997; 40: 706–710.
Engert JC, Vohl MC, Williams SM, Lepage P, Loredo-Osti JC, Faith J, Dore C, Renaud Y, Burtt NP, Villeneuve A, Hirschhorn JN, Altshuler D, Groop LC, Despres JP, Gaudet D, Hudson TJ . 5′ flanking variants of resistin are associated with obesity. Diabetes 2002; 51: 1629–1634.
Rosmond R, Bouchard C, Björntorp P . Allelic variants in the GABAα6 receptor subunit gene (GABRA6) is associated with abdominal obesity and cortisol secretion. Int J Obes Relat Metab Disord 2002; 26: 938–941.
Siani A, Iacone R, Russo O, Barba G, Russo P, Cappuccio FP, Galletti F, Strazzullo P . Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men. Obes Res 2001; 9: 722–726.
Draper N, Echwald SM, Lavery GG, Walker EA, Fraser R, Davies E, Sorensen TI, Astrup A, Adamski J, Hewison M, Connell JM, Pedersen O, Stewart PM . Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab 2002; 87: 4984–4990.
Rosmond R, Bouchard C, Björntorp P . 5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res 2002; 10: 585–589.
Weaver JU, Kopelman PG, Hitman GA . Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene. Eur J Clin Invest 1992; 22: 265–270.
Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, Carlsson B, Bouchard C, Bjorntorp P . Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000; 85: 3126–3131.
Wauters M, Mertens I, Chagnon M, Rankinen T, Considine RV, Chagnon YC, Van Gaal LF, Bouchard C . Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord 2001; 25: 714–720.
Mattevi VS, Zembrzuski VM, Hutz MH . Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord 2002; 26: 1179–1185.
Klannemark M, Orho M, Langin D, Laurell H, Holm C, Reynisdottir S, Arner P, Groop L . The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity. Diabetologia 1998; 41: 1516–1522.
Hoffstedt J, Arner P, Schalling M, Pedersen NL, Sengul S, Ahlberg S, Iliadou A, Lavebratt C . A common hormone-sensitive lipase i6 gene polymorphism is associated with decreased human adipocyte lipolytic function. Diabetes 2001; 50: 2410–2413.
Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM . Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiol Genomics 2000; 3: 39–44.
Hegele RA, Huff MW, Young TK . Common genomic variation in LMNA modulates indexes of obesity in Inuit. J Clin Endocrinol Metab 2001; 86: 2747–2751.
Boucher N, Lanouette CM, Larose M, Perusse L, Bouchard C, Chagnon YC . A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med 2002; 8: 158–165.
Rosmond R, Chagnon M, Bouchard C, Björntorp P . A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia 2001; 44: 1335–1338.
Bray MS, Boerwinkle E, Hanis CL . Sequence variation within the neuropeptide Y gene and obesity in Mexican Americans. Obes Res 2000; 8: 219–226.
Buemann B, Vohl MC, Chagnon M, Chagnon YC, Gagnon J, Perusse L, Dionne F, Despres JP, Treblay A, Nadeau A, Bouchard C . Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 1997; 5: 186–192.
Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, Carlsson B, Bouchard C, Bjorntorp P . A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic–pituitary–adrenal axis. Obes Res 2000; 8: 211–218.
Dobson MG, Redfern CP, Unwin N, Weaver JU . The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab 2001; 86: 2270–2274.
Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P . Impact of the peroxisome roliferator activated receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 2000; 24: 195–199.
Hsueh WC, Cole SA, Shuldiner AR, Beamer BA, Blangero J, Hixson JE, MacCluer JW, Mitchell BD . Interactions between variants in the β3-adrenergic receptor and peroxisome proliferator-activated receptor- γ2 genes and obesity. Diabetes Care 2001; 24: 672–677.
Esterbauer H, Oberkofler H, Linnemayr V, Iglseder B, Hedegger M, Wolfsgruber P, Paulweber B, Fastner G, Krempler F, Patsch W . Peroxisome proliferator-activated receptor-γ coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes 2002; 51: 1281–1286.
Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, Cowley AW, Hamet P . Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 2000; 36: 14–19.
Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID . Association of the TNF-α-308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002; 10: 401–407.
Fernandez-Real JM, Vendrell J, Ricart W, Broch M, Gutierrez C, Casamitjana R, Oriola J, Richart C . Polymorphism of the tumor necrosis factor-α receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care 2000; 23: 831–837.
Yanovski JA, Diament AL, Sovik KN, Nguyen TT, Li H, Sebring NG, Warden CH . Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African, American white and Asian children. Am J Clin Nutr 2000; 71: 1405–1420.
Cassell PG, Saker PJ, Huxtable SJ, Kousta E, Jackson AE, Hattersley AT, Frayling TM, Walker M, Kopelman PG, Ramachandran A, Snehelatha C, Hitman GA, McCartht MI . Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia 2000; 43: 1558–1564.
Lander ES, Schork NJ . Genetic dissection of complex traits. Science 1994; 265: 2037–2048.
Snitker S, Macdonald I, Ravussin E, Astrup A . The sympathetic nervous system and obesity: role in aetiology and treatment. Obes Rev 2000; 1: 5–15.
van Baak MA . The peripheral sympathetic nervous system in human obesity. Obes Rev 2001; 2: 3–14.
Alvarez GE, Beske SD, Ballard TP, Davy KP . Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533–2536.
Reihsaus E, Innis M, MacIntyre N, Liggett SB . Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334–339.
Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arner P . Human β2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte β2 adrenoceptor function. J Clin Invest 1997; 100: 3005–3013.
Hellström L, Large V, Reynisdottir S, Wahrenberg H, Arner P . The different effects of a Gln27Glu β2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med 1999; 245: 253–259.
Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shigemoto S, Yamada K, Akanuma Y, Ohashi Y, Kimura S, Yazaki Y, Kadowaki T . The Gln27Glu β2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 1999; 258: 138–140.
Hayakawa T, Nagai Y, Kahara T, Yamashita H, Takamura T, Abe T, Nomura G, Kobayashi K . Gln27Glu and Arg16Gly polymorphisms of the β2-adrenergic receptor gene are not associated with obesity in Japanese men. Metabolism 2000; 49: 1215–1218.
Kim SH, Kim DJ, Seo IA, Min YK, Lee MS, Kim KW, Lee MK . Significance of β2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism 2002; 51: 833–837.
Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343–347.
Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD . Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352–354.
Elbein SC, Hoffman M, Barrett K, Wegner K, Miles C, Bachman K, Berkowitz D, Shuldiner AR, Leppert MF, Hasstedt S . Role of the β3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 1996; 81: 4422–4427.
Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT, Oppert JM, Perusse L, Sjostrom L, Bouchard C . The Trp64Arg mutation of the β3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996; 98: 2086–2093.
Moriarty M, Wing RR, Kuller LH, Ferrell RE . Trp64Arg substitution in the β3-adrenergic receptor does not relate to body weight in healthy, premenopausal women. Int J Obes Relat Metab Disord 1997; 21: 826–829.
Rissanen J, Kuopusjarvi J, Pihlajamaki J, Sipilainen R, Heikkinen S, Vanhala M, Kekalainen P, Kuusisto J, Laakso M . The Trp64Arg polymorphism of the β3-adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 1997; 20: 1319–1323.
Hegele RA, Harris SB, Hanley AJ, Azouz H, Connelly PW, Zinman B . Absence of association between genetic variation of the β3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 1998; 21: 851–854.
Buettner R, Schaffler A, Arndt H, Rogler G, Nusser J, Zietz B, Enger I, Hugl S, Cuk A, Scholmerich J, Palitzsch KD . The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 1998; 83: 2892–2897.
Tchernof A, Starling RD, Walston JD, Shuldiner AR, Dvorak RV, Silver K, Matthews DE, Poehlman ET . Obesity-related phenotypes and the β3-adrenoceptor gene variant in postmenopausal women. Diabetes 1999; 48: 1425–1428.
Urhammer SA, Hansen T, Borch-Johnsen K, Pedersen O . Studies of the synergistic effect of the Trp/Arg64 polymorphism of the β3-adrenergic receptor gene and the −3826 A → G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 2000; 85: 3151–3154.
Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD . Pharmacological characterization of a recently described human β3-adrenergic receptor mutant. Endocrinology 1996; 137: 2638–2641.
Li LS, Lönnqvist F, Luthman H, Arner P . Phenotypic characterization of the Trp64Arg polymorphism in the β3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996; 39: 857–860.
Pietri-Rouxel F, St John Manning B, Gros J, Strosberg AD . The biochemical effect of the naturally occurring Trp64 → Arg mutation on human β3-adrenoceptor activity. Eur J Biochem 1997; 247: 1174–1179.
Tataranni PA, Pratley R, Shuldiner A, Ravussin E . β3-Adrenergic receptor gene variant and lipid metabolism in Pima Indians. Diabetologia 1997; 40: 123–124.
Hoffstedt J, Poirier O, Thorne A, Lönnqvist F, Herrmann SM, Cambien F, Arner P . Polymorphism of the human β3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 1999; 48: 203–205.
Umekawa T, Yoshida T, Sakane N, Kogure A, Kondo M, Honjyo H . Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3-adrenoceptor agonist in human omental adipocytes. Diabetes 1999; 48: 117–120.
Jequier E . Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002; 967: 379–388.
Friedman JM, Halaas JL . Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770.
Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF . The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996; 45: 992–994.
Matsuoka N, Ogawa Y, Hosoda K, Matsuda J, Masuzaki H, Miyawaki T, Azuma N, Natsui K, Nishimura H, Yoshimasa Y, Nishi S, Thompson DB, Nakao K . Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia 1997; 40: 1204–1210.
Sing CF, Davignon J . Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985; 37: 268–285.
Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES . The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76–80.
Björntorp P . Thrifty genes and human obesity. Are we chasing ghosts? Lancet 2001; 358: 1006–1008.
Heo M, Leibel RL, Boyer BB, Chung WK, Koulu M, Karvonen MK, Pesonen U, Rissanen A, Laakso M, Uusitupa MI, Chagnon Y, Bouchard C, Donohoue PA, Burns TL, Shuldiner AR, Silver K, Andersen RE, Pedersen O, Echwald S, Sorensen TI, Behn P, Permutt MA, Jacobs KB, Elston RC, Hoffman DJ, Allison DB . Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity. Genetics 2001; 159: 1163–1178.
Heo M, Leibel RL, Fontaine KR, Boyer BB, Chung WK, Koulu M, Karvonen MK, Pesonen U, Rissanen A, Laakso M, Uusitupa MI, Chagnon Y, Bouchard C, Donohoue PA, Burns TL, Shuldiner AR, Silver K, Andersen RE, Pedersen O, Echwald S, Sorensen TI, Behn P, Permutt MA, Jacobs KB, Elston RC, Hoffman DJ, Gropp E, Allison DB . A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference. Int J Obes Relat Metab Disord 2002; 26: 640–646.
Rosmond R . The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res 2002; 10: 1078–1086.
Rosmond R, Bouchard C, Björntorp P . Tsp509I polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study. BMJ 2001; 322: 652–653.
Echwald SM, Sørensen TI, Andersen T, Pedersen O . The Asn363Ser variant of the glucocorticoid receptor gene is not associated with obesity or weight gain in Danish men. Int J Obes Relat Metab Disord 2001; 25: 1563–1565.
de Lange P, Koper JW, Huizenga NA, Brinkmann AO, de Jong FH, Karl M, Chrousos GP, Lamberts SW . Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol 1997; 11: 1156–1164.
van Rossum EF, Koper JW, Huizenga NA, Uitterlinden AG, Janssen JA, Brinkmann AO, Grobbee DE, de Jong H, van Duyn CM, Pols HA, Lamberts SW . A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 2002; 51: 3128–3134.
Abbas AK, Lichtman AH, Pober JS . Cellular and molecular immunology. WB Saunder: Philadelphia, 2000.
Wilson AG, di Giovine FS, Blakemore AI, Duff GW . Single base polymorphism in the human tumour necrosis factor α (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW . Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195–3199.
Kroeger KM, Carville KS, Abraham LJ . The −308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391–399.
Norman RA, Bogardus C, Ravussin E . Linkage between obesity and a marker near the tumor necrosis factor-α locus in Pima Indians. J Clin Invest 1995; 96: 158–162.
Walston J, Seibert M, Yen C, Cheskin L, Andersen R . Tumor necrosis factor-α −238 and −308 polymorphisms do not associate with traits related to obesity and insulin resistance. Diabetes 1999; 48: 2096–2098.
Hotamisligil GS . Mechanisms of TNF-α-induced insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 119–125.
Rasmussen SK, Urhammer SA, Jensen JN, Hansen T, Borch-Johnsen K, Pedersen O . The −238 and −308 G → A polymorphisms of the tumor necrosis factor α gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab 2000; 85: 1731–1734.
Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P . Excessive fat accumulation is associated with the TNFα −308 G/A promoter polymorphism in women but not in men. Diabetologia 2000; 43: 117–120.
Rosmond R, Chagnon M, Bouchard C, Björntorp P . G-308A polymorphism of the tumor necrosis factor α gene promoter and salivary cortisol secretion. J Clin Endocrinol Metab 2001; 86: 2178–2180.
Allison DB, Schork NJ . Selected methodological issues in meiotic mapping of obesity genes in humans: issues of power and efficiency. Behav Genet 1997; 27: 401–421.
Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O'Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S, Weinberg C . Reporting, appraising, and integrating data on genotype prevalence and gene–disease associations. Am J Epidemiol 2002; 156: 300–310.
Hajeer AH, Hutchinson IV . TNF-α gene polymorphism: clinical and biological implications. Microsc Res Tech 2000; 50: 216–228.
Daly AK, Day CP . Candidate gene case–control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 2001; 52: 489–499.
Altshuler D, Daly M, Kruglyak L . Guilt by association. Nat Genet 2000; 26: 135–137.
Parsons TJ, Power C, Manor O . Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study. BMJ 2001; 323: 1331–1335.
Sørensen TI, Echwald SM . Obesity genes. BMJ 2001; 322: 630–631.
Brunner E, McCarthy N . Adult obesity depends on genes and environment. BMJ 2001; 323: 52.
About this article
Cite this article
Rosmond, R. Association studies of genetic polymorphisms in central obesity: a critical review. Int J Obes 27, 1141–1151 (2003). https://doi.org/10.1038/sj.ijo.0802397
This article is cited by
Nature Communications (2015)
Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies
International Journal of Obesity (2007)